Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Parkinson's disease: promising strategies to tame symptoms.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2012 Nov;24(10):4-5. No abstract available.

PMID:
23362529
2.

Caffeine in Parkinson disease: better for cruise control than snooze patrol?

Schwarzschild MA.

Neurology. 2012 Aug 14;79(7):616-8. doi: 10.1212/WNL.0b013e318263580e. Epub 2012 Aug 1. No abstract available.

PMID:
22855870
3.

Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease.

Morelli M.

Exp Neurol. 2003 Nov;184(1):20-3. Review. No abstract available.

PMID:
14637073
4.

Exercise and Parkinson's: benefits for cognition and quality of life.

Cruise KE, Bucks RS, Loftus AM, Newton RU, Pegoraro R, Thomas MG.

Acta Neurol Scand. 2011 Jan;123(1):13-9. doi: 10.1111/j.1600-0404.2010.01338.x.

PMID:
20199518
5.

A randomized trial of deep-brain stimulation for Parkinson's disease.

Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section..

N Engl J Med. 2006 Aug 31;355(9):896-908. Erratum in: N Engl J Med. 2006 Sep 21;355(12):1289.

6.

[Caffeine in Parkinson's disease].

Ferré S.

Med Clin (Barc). 2008 Nov 22;131(18):710-5. Spanish. No abstract available.

PMID:
19087830
7.

Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of life.

Puente V, De Fabregues O, Oliveras C, Ribera G, Pont-Sunyer C, Vivanco R, Cucurella G, Giralt E, Delgado T, Garcia C, Seoane A, Campo R.

Parkinsonism Relat Disord. 2010 Mar;16(3):218-21. doi: 10.1016/j.parkreldis.2009.07.015. Epub 2009 Sep 16.

PMID:
19762271
8.

Exercise: a possible adjunct therapy to alleviate early Parkinson disease.

Konerth M, Childers J.

JAAPA. 2013 Apr;26(4):30-3. Review. No abstract available.

PMID:
23610834
10.

[Health-related quality of life in Parkinson's disease].

Cano-de la Cuerda R, Vela-Desojo L, Miangolarra-Page JC, Macías-Macías Y, Muñoz-Hellin E.

Medicina (B Aires). 2010;70(6):503-7. Spanish.

PMID:
21163736
11.

Meratran with reserpine; adjunctive use in the treatment of Parkinson's disease.

BUTTON JC.

J Am Osteopath Assoc. 1956 Apr;55(8):501-2. No abstract available.

PMID:
13306632
12.

Depressive symptoms and perception of quality of life in Parkinson's disease.

Scalzo P, Kummer A, Cardoso F, Teixeira AL.

Arq Neuropsiquiatr. 2009 Jun;67(2A):203-8.

13.

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL.

N Engl J Med. 1998 Oct 15;339(16):1105-11.

14.

Treatment with subthreshold doses of caffeine plus trihexyphenidyl fully restores locomotion and exploratory activity in reserpinized rats.

Moo-Puc RE, Villanueva-Toledo J, Arankowsky-Sandoval G, Alvarez-Cervera F, Góngora-Alfaro JL.

Neurosci Lett. 2004 Sep 9;367(3):327-31.

PMID:
15337259
15.

Treatment options for non-motor symptoms in late-stage Parkinson's disease.

Coelho M, Ferreira J, Rosa M, Sampaio C.

Expert Opin Pharmacother. 2008 Mar;9(4):523-35. doi: 10.1517/14656566.9.4.523. Review.

PMID:
18312155
16.

Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease.

Xu K, Bastia E, Schwarzschild M.

Pharmacol Ther. 2005 Mar;105(3):267-310. Epub 2004 Dec 21. Review.

PMID:
15737407
17.

Effect of exercise on perceived quality of life of individuals with Parkinson's disease.

Baatile J, Langbein WE, Weaver F, Maloney C, Jost MB.

J Rehabil Res Dev. 2000 Sep-Oct;37(5):529-34.

PMID:
11322151
18.

A young onset Parkinson's patient: a case study.

Jung SK.

J Neurosci Nurs. 2004 Oct;36(5):273-7.

PMID:
15524245
19.
20.

Distribution of motor impairment influences quality of life in Parkinson's disease.

Stewart KC, Fernandez HH, Okun MS, Jacobson CE, Hass CJ.

Mov Disord. 2008 Jul 30;23(10):1466-8. doi: 10.1002/mds.22162.

PMID:
18546324

Supplemental Content

Support Center